Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | $14.2M | -- | -- | -$0.72 | -- |
| 11/10/2025 | Q3 | $16M | $14.2M | -$0.49 | -$0.80 | $0.30 |
| 08/11/2025 | Q2 | $18.8M | $24.5M | -$0.34 | -$0.85 | $0.51 |
| 05/08/2025 | Q1 | $23.3M | $25.5M | -$0.52 | -$1.10 | $0.58 |
| 03/06/2025 | Q4 | $44.6M | $21M | -$1.11 | -$0.49 | -$0.62 |
| 11/07/2024 | Q3 | $36.6M | $38.8M | -$0.26 | -$1.02 | $0.76 |
| 08/05/2024 | Q2 | $22.2M | $46M | -$0.64 | -$1.57 | $0.93 |
| 05/08/2024 | Q1 | $17.7M | $32.6M | -$1.00 | -$1.14 | $0.14 |
| 03/07/2024 | Q4 | $37.9M | $25.1M | -$0.32 | -$1.05 | $0.73 |
| 11/14/2023 | Q3 | -- | -- | -$0.61 | -$1.63 | $1.02 |
| 08/07/2023 | Q2 | -- | -- | -$1.98 | -$0.42 | -$1.56 |
| 05/09/2023 | Q1 | -- | -- | $1.87 | $0.65 | $1.22 |
| 03/28/2023 | Q4 | -- | -- | $4.43 | $1.23 | $3.20 |
| 11/09/2022 | Q3 | -- | -- | -$1.33 | -$1.81 | $0.48 |
| 08/09/2022 | Q2 | -- | -- | -$0.82 | -$1.88 | $1.06 |
| 05/09/2022 | Q1 | -- | -- | -$1.94 | -$1.40 | -$0.54 |
| 02/28/2022 | Q4 | -- | -- | -$1.47 | -$1.69 | $0.22 |
| 11/08/2021 | Q3 | -- | -- | -$2.05 | -$1.52 | -$0.53 |
| 08/10/2021 | Q2 | -- | -- | -$2.07 | -$2.25 | $0.18 |
| 05/10/2021 | Q1 | -- | -- | -$2.15 | -$1.23 | -$0.92 |
| 03/01/2021 | Q4 | -- | -- | -$1.36 | -$0.86 | -$0.50 |
| 11/09/2020 | Q3 | -- | -- | -$0.92 | -$0.49 | -$0.43 |
| 08/10/2020 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.67 | -$0.72 | $0.05 |
| 03/11/2020 | Q4 | -- | -- | -$0.76 | -$0.63 | -$0.13 |
| 11/07/2019 | Q3 | -- | -- | -$0.56 | -$0.65 | $0.09 |
| 08/15/2019 | Q2 | -- | -- | -- | -$0.67 | -- |
| 05/13/2019 | Q1 | -- | -- | -- | -$0.60 | -- |
| 03/18/2019 | Q4 | -- | -- | -- | -$0.52 | -- |
| 10/01/2018 | Q3 | -- | -- | -- | -$0.35 | -- |
| 06/30/2018 | Q2 | -- | -- | -- | -$0.34 | -- |
| 05/14/2018 | Q1 | -- | -- | -- | -$0.33 | -- |
| 12/31/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/09/2017 | Q3 | -- | -- | -- | -- | -- |
| 08/11/2017 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -- | -- | -- |
| 02/15/2017 | Q4 | -- | -- | -- | -- | -- |
| 11/15/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/30/2016 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
Arcturus Therapeutics Holdings, Inc. reported $14.2M worth of top line sales in its most recent quarter.
Arcturus Therapeutics Holdings, Inc. announced earnings per share of -$0.49 which represents a beat of analyst forecast a -$0.80 per share.
Arcturus Therapeutics Holdings, Inc. reported $13.4M that represents $0.49 per share over the last quarter.
Arcturus Therapeutics Holdings, Inc.'s earnings are forecast to decrease from -$3.00 per share to -$2.38 per share next year representing a decrease of -30.52%.
Arcturus Therapeutics Holdings, Inc.'s next earnings date is March 5, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.